Helicobacter pylori infection is positively associated with gallstones: A large-scale cross-sectional study in Japan

Journal of Gastroenterology

Volumn 49, Issue 5, 2014, Pages 882-889

  Takahashi, Yu ^a   Yamamichi, Nobutake ^a   Shimamoto, Takeshi ^b   Mochizuki, Satoshi ^a   Fujishiro, Mitsuhiro ^a   Takeuchi, Chihiro ^a   Sakaguchi, Yoshiki ^a   Niimi, Keiko ^a   Ono, Satoshi ^a   Kodashima, Shinya ^a   Mitsushima, Toru ^b   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KAMEDA MEDICAL CENTER   (Japan)

Author keywords

Cross sectional study; Gallstone; Helicobacter pylori

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BACTERIUM ANTIBODY; CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PEPSINOGEN I; PEPSINOGEN II; PROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ERADICATION THERAPY; FEMALE; GALLSTONE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOGLOBIN BLOOD LEVEL; HUMAN; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; COMPLICATION; GALLSTONES; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; RISK FACTOR; STATISTICAL MODEL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; GALLSTONES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84901398932     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0832-z     Document Type: Article

References (44)

1. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet. 2006;368:230-9. (Pubitemid 44037798)
2. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am. 2010;39: 157-69, vii.
3. Everhart JE, Yeh F, Lee ET, Hill MC, Fabsitz R, Howard BV, et al. Prevalence of gallbladder disease in American Indian populations: findings from the Strong Heart Study. Hepatology. 2002;35:1507-12. (Pubitemid 34966906)
4. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol. 1995;141:158-65.
5. Kono S, Eguchi H, Honjo S, Todoroki I, Oda T, Shinchi K, et al. Cigarette smoking, alcohol use, and gallstone risk in Japanese men. Digestion. 2002;65:177-83. (Pubitemid 34914037)
6. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology. 1997;26:809-18. (Pubitemid 27413641)
7. Everhart JE, Khare M, Hill M, Maurer KR. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 1999;117:632-9. (Pubitemid 29409249)
8. Otani T, Iwasaki M, Yamamoto S, Sobue T, Hanaoka T, Inoue M, et al. Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev. 2003;12:1492-500. (Pubitemid 38031754)
9. Katsika D, Tuvblad C, Einarsson C, Lichtenstein P, Marschall HU. Body mass index, alcohol, tobacco and symptomatic gallstone disease: a Swedish twin study. J Intern Med. 2007;262: 581-7. (Pubitemid 47620508)
10. Heaton KW, Braddon FE, Mountford RA, Hughes AO, Emmett PM. Symptomatic and silent gall stones in the community. Gut. 1991;32:316-20.
11. Marschall HU, Einarsson C. Gallstone disease. J Intern Med. 2007;261:529-42. (Pubitemid 46835981)
12. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep. 2005;7:132-40. (Pubitemid 40796699)
13. Smelt AH. Triglycerides and gallstone formation. Clin Chim Acta. 2010;411:1625-31.
14. Thijs C, Knipschild P, Brombacher P. Serum lipids and gallstones: a case-control study. Gastroenterology. 1990;99:843-9. (Pubitemid 20243380)
15. Jonkers IJ, Smelt AH, Ledeboer M, Hollum ME, Biemond I, Kuipers F, et al. Gall bladder dysmotility: a risk factor for gall stone formation in hypertriglyceridaemia and reversal on triglyceride lowering therapy by bezafibrate and fish oil. Gut. 2003;52:109-15. (Pubitemid 36020775)
16. Yang MH, Chen TH, Wang SE, Tsai YF, Su CH, Wu CW, et al. Biochemical predictors for absence of common bile duct stones in patients undergoing laparoscopic cholecystectomy. Surg Endosc. 2008;22:1620-4.
17. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology. 2005;41:1138-43. (Pubitemid 40593922)
18. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995;109:136-41.
19. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet. 1992;339:893-5.
20. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-6.
21. Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8:8-14. (Pubitemid 46189204)
22. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut. 1999;44:693-7. (Pubitemid 29195918)
23. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE. Gastric acidity in older adults. JAMA. 1997;278:659-62. (Pubitemid 27373840)
24. Gatta L, Vakil N, Ricci C, Osborn JF, Tampieri A, Perna F, et al. Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol. 2004;99:823-9. (Pubitemid 39090207)
25. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56:772-81. (Pubitemid 46854190)
26. Ruhl CE, Everhart JE. Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology. 2000;31:299-303. (Pubitemid 30078591)
27. Biddinger SB, Haas JT, Yu BB, Bezy O, Jing E, Zhang W, et al. Hepatic insulin resistance directly promotes formation of cholesterol gallstones. Nat Med. 2008;14:778-82.
28. Di Ciaula A, Wang DQ, Wang HH, Bonfrate L, Portincasa P. Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am. 2010;39: 245-64, viii-ix.
29. Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR. Statin use and risk of gallstone disease followed by cholecystectomy. JAMA. 2009;302:2001-7.
30. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Statin use and the risk of cholecystectomy in women. Gastroenterology. 2009;136:1593-600.
31. Korstanje A, van Eeden S, Offerhaus JA, Waltman FL, Hartog G, Roelandse FW, et al. Comparison between serology and histology in the diagnosis of advanced gastric body atrophy: a study in a Dutch primary community. J Clin Gastroenterol. 2008;42:18-22.
32. Chen CH, Huang MH, Yang JC, Nien CK, Etheredge GD, Yang CC, et al. Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey. J Gastroenterol Hepatol. 2006;21:1737-43. (Pubitemid 44410888)
33. Mendez-Sanchez N, Tanimoto MA, Cobos E, Roldan-Valadez E, Uribe M. Cholesterolosis is not associated with high cholesterol levels in patients with and without gallstone disease. J Clin Gastroenterol. 1997;25:518-21. (Pubitemid 27528149)
34. Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009;136:1863-73.
35. Myung SJ, Kim MH, Shim KN, Kim YS, Kim EO, Kim HJ, et al. Detection of Helicobacter pylori DNA in human biliary tree and its association with hepatolithiasis. Dig Dis Sci. 2000;45:1405-12.
36. Silva CP, Pereira-Lima JC, Oliveira AG, Guerra JB, Marques DL, Sarmanho L, et al. Association of the presence of Helicobacter in gallbladder tissue with cholelithiasis and cholecystitis. J Clin Microbiol. 2003;41:5615-8. (Pubitemid 37543255)
37. Chen W, Li D, Cannan RJ, Stubbs RS. Common presence of Helicobacter DNA in the gallbladder of patients with gallstone diseases and controls. Dig Liver Dis. 2003;35:237-43. (Pubitemid 41070478)
38. Abayli B, Colakoglu S, Serin M, Erdogan S, Isiksal YF, Tuncer I, et al. Helicobacter pylori in the etiology of cholesterol gallstones. J Clin Gastroenterol. 2005;39:134-7. (Pubitemid 40130026)
39. Farshad S, Alborzi A, Malek Hosseini SA, Oboodi B, Rasouli M, Japoni A, et al. Identification of Helicobacter pylori DNA in Iranian patients with gallstones. Epidemiol Infect. 2004;132:1185-9. (Pubitemid 39642403)
40. Figura N, Cetta F, Angelico M, Montalto G, Cetta D, Pacenti L, et al. Most Helicobacter pylori-infected patients have specific antibodies, and some also have H. pylori antigens and genomic material in bile: is it a risk factor for gallstone formation? Dig Dis Sci. 1998;43:854-62. (Pubitemid 28176477)
41. Neri V, Margiotta M, de Francesco V, Ambrosi A, Valle ND, Fersini A, et al. DNA sequences and proteic antigens of H. pylori in cholecystic bile and tissue of patients with gallstones. Aliment Pharmacol Ther. 2005;22:715-20. (Pubitemid 41475333)
42. Hamada T, Yokota K, Ayada K, Hirai K, Kamada T, Haruma K, et al. Detection of Helicobacter hepaticus in human bile samples of patients with biliary disease. Helicobacter. 2009;14:545-51.
43. Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR, et al. Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology. 2005;128:1023-33. (Pubitemid 40523552)
44. Hofmann AF. Helicobacter and cholesterol gallstones: do findings in the mouse apply to man? Gastroenterology. 2005;128: 1126-9. (Pubitemid 40523564)